1 H MRS) has proven its diagnostic potential in a variety of conditions. However, MRS is not yet widely used in clinical routine because of the lack of experts on its diagnostic interpretation. Although data-based decision support systems exist to aid diagnosis, they often take for granted that the data is of good quality, which is not always the case in a real application context. Systems based on models built with bad quality data are likely to underperform in their decision support tasks. In this study, we propose a system to filter out such bad quality data. It is based on convex Non-Negative Matrix Factorization models, used as a dimensionality reduction procedure, and on the use of several classifiers to discriminate between good and bad quality data.
Introduction
Proton magnetic resonance spectroscopy ( 1 H MRS, henceforth only referred to as MRS) is a magnetic resonance modality that provides metabolic information about an investigated tissue volume, thus becoming a tool for metabolomics. MRS is inherently non-invasive and can be used either on its own, or in conjunction with other MR mo-dalities [1] with the aim to improve diagnostic accuracy. Although MRS can be used to investigate a wide range of tissue types [2] , it is mainly used for diseases of the central nervous system (CNS), and has proven a powerful tool in assessing a broad spectrum of diseases such as metabolic disorders, epilepsy, Alzheimer and Parkinson, amongst others. But, by far, its most common application is on brain tumors diagnostic assistance [2] .
MRS can be single-voxel (SV), where the signal comes from a volume of interest, or multi-voxel, using a grid/matrix of many contiguous SVs (actually, SV-like spectral vectors). MRS has several parameters of importance that should be mentioned. First of all, echo time, which can be either short (STE, lower than 40 ms), or long (LTE, higher than 40 ms), controlling what metabolites can be better seen in the spectrum. STE only allows for positive peaks in the spectrum whereas LTE can also have negative peaks. Another important parameter is field strength (measured in Tesla, T) which, in laymen terms, determines how far apart the peaks of the metabolites are, and how many metabolites can be detected. A typical field strength used in clinical routine is 1.5 T. Figure 1 shows an example of an MR spectrum.
Although MRS is a promising technique, it is not yet widely implemented in clinical routine. It can be argued that the main reason for this is the explicit need for an expert (a radiologist) to interpret the spectrum and reach a diagnostic. Previous work has been carried out to compensate for the lack of experts in MRS interpretation by using (semi-)automated classifiers or decision support systems [3] [4] [5] . The main limitation of such systems is that they assume that the spectra are of consistently good quality. Unfortunately, the definition of 'good quality' has yet to be clearly established, and by this we mean that the gold standard is human-dependent and, although some guidelines have been proposed [3, 6] , it may vary from expert to expert. Furthermore, multiple types of artifacts can contaminate the signal; an extensive gallery of such artefacts is presented in [7] . Figure 2 shows an example of a bad quality spectrum (compare to Figure 1 , which corresponds to a good quality spectrum).
In a previous work by van der Graaf et al. [8] , a semi-automatic filtering procedure, based on the signal-to-noise ratio (SNR) of the spectrum and the water bandwidth (WBW -defined as the line width at half of the maximum intensity of the water peak), was proposed. However, this system relies on a board of experts for validating the final decision.
A fully automated system, trained on a subset of the eTUMOR [9, 10] and INTERPRET [11, 12] SV spectra (144 SVs, 72 acceptable and 72 unacceptable), was proposed by Wright et al. [13] . The system consists of a least squares support vector machine [14] with a radial basis function kernel and fastICA [15] , which was used for dimensionality reduction. The test set comprised of 98 SVs (58 acceptable and 40 unacceptable) from the eTUMOR database. The results of this study were encouraging (an accuracy of 88%), but we argue that this might be due to several reasons that might not hold up in a real clinical setting. First of all, because the number of cases analyzed was relatively low, something that can be seen as a detrimental for the generalization power of the system. Another and more important aspect to consider is that the two classes are fairly balanced for training and testing -again affecting generalization but also performance metrics. in cNMF, F is constrained to lie in the column space of the input data X, so that the cNMF formula can be written as:
where A fully determines F. G is also called the mixing matrix, as it holds the coefficients to recompose a specific data sample. It is a well-known fact that the results of the cNMF algorithm are dependent on the initialization scheme; in our implementation, we use the k-means++ algorithm [19] . It should be mentioned that there is no fully established method for choosing the optimal number of sources/basis vectors.
Implementation details
Some of the classifiers used in this study are not parameterless. LR was used in its basic variant, as well as with regularization, namely l2 -LRCV. AdaBoost was built using fifty decision trees as estimators. In the case of RF, fifty estimators were used; bootstrap samples of the training set were used to build the trees and the maximum number of features considered when looking for the best split was the square root of the total number of features. All nodes were expanded until all leaves were rendered pure. LR, LRCV and RF versions that take into account class imbalance by assigning a proportional weight to the less represented class were also built -they will be in turn be named LRA, LRCVA and RFA.
Regarding the details of our proposed system, we extracted from three up to eleven sources. A maximum of eleven sources was extracted because, as reported in [6] , one should account usually for up to 9 technical requirements to make the spectrum clinically interpretable. The 2 remaining sources should account for the variability that is present in the 'good' class. We then used a 10-fold stratified cross-validation loop to split the mixing matrix in training and test subsets; trained the classifiers; and computed the accuracy, sensitivity, specificity, F1 score, and balanced error rate. Final results are reported as averaged performance metrics.
Results
We start by presenting the eleven extracted sources in Figure 3 . Several aspects should be mentioned: first, that, even though the extracted sources are akin to the input space, they are not true spectra as such and, therefore, the x and y axes are left unlabeled (however the x axis would correspond to the [7.1 -2.7] ppm range and the y axis to the [-20 ,40] a.u. range). Another thing to stress is that some of the negative peaks are not completely shown in this figure, for two reasons: first, because in STE, negative peaks are not possible and are directly regarded as artefacts; second, a more practical reason was not to undermine the amplitude of the positive peaks. An important aspect to note is that we have found five sources pertaining to good spectra, and only six artefactual sources.
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Discussion
From Figure 3 , we see that we have obtained different results to those expected according to our hypothesis; 5 sources represent good spectra. They correspond to normal brain tissue, necrotic tissue, low grade glial tumor, and meningioma, and necrosis again (Figure 3: B, F, H, J, K) .
These results are in line with previous work that showed that a clear separation could be drawn between these classes when dealing only with good quality spectra [11, 18] . The two sources corresponding to necrosis are in line with the results reported in [18, 20] . Regarding the artifactual sources, we observe that four of them ( Figure  3: A, C, D, G) can be regarded as pure artifacts, while the rest can be regarded as a combination of two superimposed artefacts (Figure 3 : E, I). Because five sources corresponding to the good class were found, we re-run the source extraction experiment for 13 sources (the five good sources plus the eight bad sources from our initial hypothesis; we subtracted one because we saw that water suppression tends to mix with other artefacts). In this iteration we found the same five sources corresponding to good spectra, plus eight artifactual sources. The nature of the rest of the artifactual sources was the same as that of the ones previously extracted; they mix differently, however. Classification results improve marginally with the addition of the 2 extra sources and are not reported herein.
Regarding the classification results, it is important to take into account that the class imbalance was approximately 8 to 2 in favor of the good class, which implies that accuracies in Table 1 could have been achieved just by always predicting the good class. Because of this, the most important metric to take into account is the sensitivity (how good the model is at telling if a predicted bad spectrum is really a bad spectrum), where almost all classifiers perform poorly -indicating that the problem at hand cannot be well-described by our dimensionality reduction scheme. However, LRA and LRCVA exhibit good sensitivity, which can be justified by the fact that they give higher weights for the bad class. This would imply that our feature space is linearly separable, but does not obey a normal distribution (otherwise LDA would have also had a high sensitivity, which is not the case).
As we previously mentioned, the original labeling of the analyzed data was performed by two or three expert spectroscopists; some cases were labeled as bad, but still one of the experts deemed it to be of acceptable quality. As such, we removed those 'borderline' spectra from the testing phase of our system, in order to see if the performance metrics would improve. The results, presented in Table 2 , show that sensitivity improved for all classifiers, while other metrics did not change significantly.
One limitation of our system is that the cNMF optimization process is known to fall into local minima and, up to date, there is no way to assess whether the algorithm converged to the optimal minimum or not. In our case, this would translate into obtaining slightly different sources depending on the run of the algorithm (and thus on initialization). This issue is meant to be addressed in future work.
Conclusion
We have presented a system that tries to address an important issue in MRS for brain tumour analysis as a metabolomics problem: data quality control. Our system used cNMF as a dimensionality reduction and artifact-identification scheme and then investigated a range of classifiers in the task of discriminating between good and bad quality spectra.
By using LRA, a sensitivity of 0.72 and a specificity of 0.78 was achieved, and by taking out the 'borderline' cases, sensitivity was increased to a value of 0.76. Our results indicate that proper separation between the two classes can be achieved, but further investigation is needed. Table 2 . Classification metrics after removing the samples that were labeled good by one expert spectrosopist and bad by the other two.
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